Although the exact mechanism by which temozolomide causes cell death is largely unknown, recent pre-clinical data suggest that there is increased apoptotic activity in multiple sarcoma cell lines treated with temozolomide and altered signaling through the PI3K/Akt pathway and the ERK 1/2 pathway [24]. Here, AKT1 is linked to sarcoma.